Brett P. Monia
Net Worth

Last updated:

What is Brett P. Monia net worth?

The estimated net worth of Dr. Brett P. Monia is at least $37,319,897 as of 12 Nov 2024. He owns shares worth $7,110,855 as insider, has earned $12,789,042 from insider trading and has received compensation worth at least $17,420,000 in Ionis Pharmaceuticals, Inc..

What is the salary of Brett P. Monia?

Dr. Brett P. Monia salary is $1,340,000 per year as Founder, Chief Executive Officer & Director in Ionis Pharmaceuticals, Inc..

How old is Brett P. Monia?

Dr. Brett P. Monia is 64 years old, born in 1961.

What stocks does Brett P. Monia currently own?

As insider, Dr. Brett P. Monia owns shares in one company:

Company Title Shares Price per share Total value
Ionis Pharmaceuticals, Inc. (IONS) Founder, Chief Executive Officer & Director 167,393 $42.48 $7,110,855

What does Ionis Pharmaceuticals, Inc. do?

Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for familial chylomicronemia syndrome and familial partial lipodystrophy. It also develops medicines for various indications that are in phase 3 study, including Eplontersen as a monthly self-administered subcutaneous injection to treat all types of TTR amyloidosis; Olezarsen for patients with severe hypertriglyceridemia (SHTG); Donidalorsen for patients with hereditary angioedema; ION363 for patients with amyotrophic lateral sclerosis; Pelacarsen for patients with established cardiovascular disease and elevated lipoprotein(a); and Tofersen to inhibit the production of superoxide dismutase 1. In addition, the company develops medicines for metabolic diseases, infectious diseases, renal diseases, ophthalmic diseases, and cancer. It has a strategic collaboration with Biogen Inc.; and collaboration and license agreement with AstraZeneca, Bayer AG, GlaxoSmithKline plc, Novartis AG, Roche, Janssen Biotech, Inc., and Flamingo Therapeutics, Inc. Ionis Pharmaceuticals, Inc. was founded in 1989 and is based in Carlsbad, California.

IONS logo
IONS
Ionis Pharmaceuticals, Inc.
$42.48

Brett P. Monia insider trading

Ionis Pharmaceuticals, Inc.

Dr. Brett P. Monia has made 52 insider trades between 2012-2024, according to the Form 4 filled with the SEC. Most recently he sold 6,630 units of IONS stock worth $252,291 on 12 Nov 2024.

The largest trade he's ever made was exercising 68,084 units of IONS stock on 16 Jan 2024. As of 12 Nov 2024 he still owns at least 167,393 units of IONS stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 6,630 $38.05 $252,291
Sale
Common Stock 387 $44.49 $17,218
Sale
Common Stock 23,501 $49.37 $1,160,315
Sale
Common Stock 2,285 $51.75 $118,249
Sale
Common Stock 32,059 $50.42 $1,616,319
Option
Common Stock 68,084 N/A N/A
Option
Restricted Stock Unit 68,084 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 17,500 $47.34 $828,450
Sale
Common Stock 17,500 $49.29 $862,575
Option
Common Stock 17,500 $47.34 $828,450
Sale
Common Stock 6,500 $49.64 $322,641
Option
Non-Qualified Stock Option (right to buy) 6,500 $47.34 $307,710
Option
Common Stock 6,500 $47.34 $307,710
Option
Non-Qualified Stock Option (right to buy) 9,140 $47.34 $432,688
Sale
Common Stock 24,000 $49.7 $1,192,800
Option
Common Stock 14,860 $47.34 $703,472
Option
Common Stock 9,140 $47.34 $432,688
Option
Non-Qualified Stock Option (right to buy) 14,860 $47.34 $703,472
Sale
Common Stock 3,770 $46 $173,420
Sale
Common Stock 18,650 $42.25 $787,963
Sale
Common Stock 24,651 $40.69 $1,003,148
Sale
Common Stock 25,066 $39.49 $989,957
Option
Restricted Stock Unit 57,267 N/A N/A
Option
Common Stock 57,267 N/A N/A
Sale
Common Stock 355 $37.49 $13,309
Option
Restricted Stock Unit 49,475 N/A N/A
Option
Common Stock 49,475 N/A N/A
Sale
Common Stock 236 N/A N/A
Option
Common Stock 34,823 N/A N/A
Option
Restricted Stock Units 34,823 N/A N/A
Sale
Common Stock 23,840 N/A N/A
Option
Common Stock 23,840 $39.87 $950,501
Option
Employee Stock Option (right to buy) 23,840 $39.87 $950,501
Option
Employee Stock Option (right to buy) 21,160 $39.87 $843,649
Option
Common Stock 21,160 $39.87 $843,649
Sale
Common Stock 21,160 $39.87 $843,649
Sale
Common Stock 314 $53.7 $16,862
Option
Restricted Stock Units 19,921 N/A N/A
Option
Common Stock 19,921 N/A N/A
Sale
Common Stock 173 $60.25 $10,423
Sale
Common Stock 5,776 $60.01 $346,618
Sale
Common Stock 210 $66.4 $13,944
Option
Common Stock 10,006 N/A N/A
Option
Restricted Stock Units 10,006 N/A N/A
Sale
Common Stock 214 $53.5 $11,449
Option
Common Stock 34,000 $14.69 $499,460
Option
Employee Stock Option (right to buy) 34,000 $14.69 $499,460
Sale
Common Stock 34,000 $14.69 $499,460
Sale
Common Stock 8,993 $7.25 $65,199
Option
Common Stock 16,493 $30.63 $505,098
Option
Employee Stock Option (right to buy) 8,993 $7.25 $65,199
Sale
Common Stock 156 N/A N/A
Sale
Common Stock 2,821 $51.76 $146,015
Option
Common Stock 6,985 N/A N/A
Option
Restricted Stock Units 6,985 N/A N/A
Sale
Common Stock 163 $50 $8,150
Sale
Common Stock 309 $51.35 $15,867
Sale
Common Stock 2,502 $46.29 $115,818
Option
Common Stock 6,402 N/A N/A
Option
Restricted Stock Units 6,402 N/A N/A
Sale
Common Stock 309 $48.6 $15,017
Sale
Common Stock 130 $52.48 $6,822
Sale
Common Stock 2,208 $41.46 $91,546
Option
Restricted Stock Units 5,335 N/A N/A
Option
Common Stock 5,543 N/A N/A
Sale
Common Stock 127 $61 $7,747
Sale
Common Stock 198 $56.3 $11,147
Option
Employee Stock Option (right to buy) 7,600 $10.29 $78,204
Option
Common Stock 7,600 $10.29 $78,204
Sale
Common Stock 7,600 $10.29 $78,204
Sale
Common Stock 1,534 $67.96 $104,257
Option
Common Stock 4,025 N/A N/A
Option
Restricted Stock Units 4,025 N/A N/A
Sale
Common Stock 76 $62.75 $4,769
Option
Employee Stock Option (right to buy) 27,344 $29.19 $798,062
Sale
Common Stock 2,344 $11.27 $26,417
Option
Common Stock 27,344 $29.19 $798,062
Sale
Common Stock 79 $31.5 $2,489
Sale
Common Stock 821 $47.08 $38,653
Option
Restricted Stock Units 2,151 N/A N/A
Option
Common Stock 2,151 N/A N/A
Sale
Common Stock 362 $39.25 $14,210
Option
Employee Stock Option (right to buy) 18,281 $35.89 $656,105
Option
Common Stock 18,281 $35.89 $656,105
Sale
Common Stock 18,281 $35.89 $656,105
Option
Common Stock 50,000 $29.76 $1,487,800
Sale
Common Stock 20,000 $15.38 $307,600
Option
Employee Stock Option (right to buy) 21,875 $24.37 $532,984
Sale
Common Stock 2,909 $25.58 $74,403
Sale
Common Stock 215 $28.7 $6,169
Option
Common Stock 9,375 $15.75 $147,656
Sale
Common Stock 9,375 $15.75 $147,656
Option
Employee Stock Option (right to buy) 9,375 $15.75 $147,656
Option
Common Stock 17,000 $21.26 $361,420
Sale
Common Stock 17,000 $21.26 $361,420
Option
Employee Stock Option (right to buy) 17,000 $21.26 $361,420
Sale
Common Stock 2,500 $11.12 $27,800
Option
Common Stock 2,500 $11.12 $27,800
Option
Employee Stock Option (right to buy) 2,500 $11.12 $27,800
Option
Employee Stock Option (right to buy) 18,240 $6.81 $124,214
Sale
Common Stock 18,240 $6.81 $124,214
Option
Common Stock 18,240 $6.81 $124,214
Sale
Common Stock 330 $14 $4,620
Option
Common Stock 737 N/A N/A
Option
Restricted Stock Units 737 N/A N/A
Sale
Common Stock 311 $10.84 $3,371
Sale
Common Stock 12,031 $5.25 $63,163
Option
Employee Stock Option (right to buy) 12,031 $5.25 $63,163
Option
Common Stock 12,031 $5.25 $63,163
Sale
Common Stock 587 $12.92 $7,584